CA2022372A1 - Excretion d'azote non proteique dans l'intestin par des derives de l'acide prostanoique - Google Patents

Excretion d'azote non proteique dans l'intestin par des derives de l'acide prostanoique

Info

Publication number
CA2022372A1
CA2022372A1 CA2022372A CA2022372A CA2022372A1 CA 2022372 A1 CA2022372 A1 CA 2022372A1 CA 2022372 A CA2022372 A CA 2022372A CA 2022372 A CA2022372 A CA 2022372A CA 2022372 A1 CA2022372 A1 CA 2022372A1
Authority
CA
Canada
Prior art keywords
intestine
excretion
improvement
acid derivatives
prostanoic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2022372A
Other languages
English (en)
Other versions
CA2022372C (fr
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of CA2022372A1 publication Critical patent/CA2022372A1/fr
Application granted granted Critical
Publication of CA2022372C publication Critical patent/CA2022372C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
CA002022372A 1989-08-09 1990-07-31 Excretion d'azote non proteique dans l'intestin par des derives de l'acide prostanoique Expired - Lifetime CA2022372C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP205895/1989 1989-08-09
JP20589589 1989-08-09

Publications (2)

Publication Number Publication Date
CA2022372A1 true CA2022372A1 (fr) 1991-02-10
CA2022372C CA2022372C (fr) 2000-05-02

Family

ID=16514522

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022372A Expired - Lifetime CA2022372C (fr) 1989-08-09 1990-07-31 Excretion d'azote non proteique dans l'intestin par des derives de l'acide prostanoique

Country Status (5)

Country Link
US (1) US5126372A (fr)
EP (1) EP0415564B1 (fr)
AT (1) ATE121624T1 (fr)
CA (1) CA2022372C (fr)
DE (1) DE69018903T2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009515948A (ja) * 2005-11-18 2009-04-16 レノビズ・カンパニー・リミテッド 有機粘土を含む腐食防止用コーティング剤組成物およびその製造方法
MX2008009650A (es) 2006-01-24 2008-11-06 R Tech Ueno Ltd Formulacion de capsula de gelatina suave.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153858A3 (fr) * 1984-02-29 1985-12-11 The Upjohn Company Application thérapeutique de prostaglandines
CA1322749C (fr) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandines de la serie d, et tranquilisants et soporifiques en contenant
CA1323364C (fr) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandines e et agents anti-ulcereux contenant celles-ci
CA1324129C (fr) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandines de la serie f
DE3869471D1 (de) * 1987-05-15 1992-04-30 Ueno Seiyaku Oyo Kenkyujo Kk Fiebersteigende zusammensetzung.
DE3850676T2 (de) * 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.
ES2051862T3 (es) * 1987-10-02 1994-07-01 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para producir un medicamento que tiene un efecto catartico.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
EP0343904B1 (fr) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Composition provoquant l'hypersphyxie

Also Published As

Publication number Publication date
EP0415564A3 (en) 1992-07-08
ATE121624T1 (de) 1995-05-15
US5126372A (en) 1992-06-30
CA2022372C (fr) 2000-05-02
DE69018903D1 (de) 1995-06-01
DE69018903T2 (de) 1995-08-24
EP0415564B1 (fr) 1995-04-26
EP0415564A2 (fr) 1991-03-06

Similar Documents

Publication Publication Date Title
AU4869690A (en) Pyrazolopyridine compound and processes for preparation thereof
CA2039197A1 (fr) Formule pharmaceutique pour le traitement de l'alcoolisme
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
CA2030433A1 (fr) Derives d'acide amine
CA2033392A1 (fr) Derives d'acide a-nor-steroide-3-carboxylique
CA2091360A1 (fr) Fuorate de mometasone monohydrate, son procede de fabrication et ses compositions pharmaceutiques
CA2181241A1 (fr) Procede pour solubiliser des agents pharmaceutiques difficilement solubles
RU92016595A (ru) Замещенные тиазолильные и замещенные пиридинильные производные, фармацевтическая композиция и способ их получения
CA2000763A1 (fr) Produit dispersant
CA2041417A1 (fr) Traitement d'une maladie du pancreas a l'aide de composes de 15-ceto-prostaglandine
CA2046069A1 (fr) Traitement des maladies inflammatoires au moyen de composes de 15-cetoprostaglandine
EP0388956A3 (fr) Dérivé de phtalinide, composition pharmaceutique et utilisation
GEP19971030B (en) Method for preparation of derivatives of 1-benzil-3-oximetil-indazolului or salts with pharmaceutically acceptable bases
CA2179733A1 (fr) Sulfamates de pseudofructopyranose anticonvulsifs
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
CA2027814A1 (fr) Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin
CA2030346A1 (fr) Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines
IL93161A0 (en) 3-phenyl-5,6-dihydrobenz(c)acridine-7-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0302967A3 (en) Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
CA2022372A1 (fr) Excretion d'azote non proteique dans l'intestin par des derives de l'acide prostanoique
FI900145L (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
CA2022323A1 (fr) Excretion d'ions potassium par des derives de l'acide prostanoique
CA2041240A1 (fr) Traitement biochimique a l'aide de 15-deshydroxy-16-oxoprostaglandine
AU7094796A (en) Sesquiterpene derivatives having antiviral activity
AU4732096A (en) Remedy for pulmonary heart

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry